SEC Form 4 · accession 0001193125-26-369063
ORTHOPEDIATRICS CORP · KIDS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Aug 24, 2026
Accepted (ET)
Aug 26, 2026 · 6:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001425450
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Aug 24, 2026 | S | 4,000 | $25.75 | D | 6,897,764 | D | |
| Common StockF4,F3 | Aug 25, 2026 | S | 16,300 | $24.74 | D | 6,881,464 | D | |
| Common StockF5,F3 | Aug 26, 2026 | S | 18,000 | $24.28 | D | 6,863,464 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.